Erigeron breviscapus slow release capsule and its preparation method
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- TSINGHUA UNIV
- Publication Date
- 2004-03-03
- Estimated Expiration
- Not applicable ยท inactive patent
Abstract
Description
technical field
[0001] The invention relates to a medicinal dosage form of breviscapine, in particular to a sustained-release capsule of breviscapine and a preparation method thereof, which is a good form of medicine for the treatment and prevention of stroke paralysis, coronary heart disease, angina pectoris and other diseases, and belongs to traditional Chinese medicine technology field. Background technique
[0002] The active ingredient scutellarin in the capsule is extracted and refined from Yunnan specialty medicinal material Erigeronbreviscapusvaut (Hand Mazz), which has the functions of dilating microvessels, improving microcirculation, reducing blood viscosity, inhibiting platelet aggregation, Promote fibrinolysis, prevent thrombolysis, increase tissue perfusion, scavenge free radicals, lower blood fat, lower blood sugar, etc. Since the 1980s, Yunnan Biopharmaceutical Factory, Yunnan Institute of Materia Medica, Yunnan Gejiu Biopharmaceutical Factory and many other...